San Juan de Miraflores, Peru Clinical Trials

A listing of San Juan de Miraflores, Peru clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 86 clinical trials
A Study to Assess the Efficacy Safety and Tolerability of Brensocatib in Participants With Non-Cystic Fibrosis Bronchiectasis

The primary objective of this study is to evaluate the effect of brensocatib at 10 mg and 25 mg compared with placebo on the rate of pulmonary exacerbations (PEs) over the 52-week treatment period.

PER003
 (5.8 away) Contact site
  • 3 views
  • 01 Aug, 2021
  • +258 other locations
A Study of Lenvatinib (MK-7902) in Pediatric Participants With Relapsed or Refractory Solid Malignancies (MK-7902-013/E7080)

The main purpose of this study is to evaluate the antitumor activity and safety of Lenvatinib (MK-7902/E7080) in children, adolescents, and young adults with relapsed or refractory solid malignancies after administration. Participants will be enrolled into initial tumor-specific cohorts which will be expanded based on observed response.

Clinica Anglo Americana ( Site 0203)
 (6.0 away) Contact site
  • 0 views
  • 23 Jul, 2021
  • +48 other locations
Posaconazole (MK-5592) Intravenous and Oral in Children With Invasive Aspergillosis (IA) (MK-5592-104)

This study will evaluate the safety, efficacy, and pharmacokinetics of posaconazole (POS) intravenous (IV) and oral formulations in pediatric participants 2 to <18 years of age with invasive aspergillosis (IA).

posaconazole
fungal infection
cancer
Instituto Nacional de Enfermedades Neopl sicas ( Site 1251)
 (2.8 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +27 other locations
A Study of Heterologous Vaccine Regimen of Adenovirus Serotype 26 Mosaic4 Human Immunodeficiency Virus(Ad26.Mos4.HIV) Adjuvanted Clade C gp140 and Mosaic gp140 to Prevent HIV-1 Infection Among Cis-gender Men and Transgender Individuals Who Have Sex With Cis-gender Men and/or Transgender Individuals

The purpose of this study is to evaluate the vaccine efficacy (VE) of a heterologous vaccine regimen utilizing Ad26.Mos4.HIV and aluminum phosphate-adjuvanted Clade C gp140 and Mosaic gp140 for the prevention of HIV-1 infection in HIV-1 seronegative cis-gender men and transgender individuals having sex with cis-gender men and/or transgender individuals.

Asociacion Civil Impacta Salud y Educacion - Barranco
 (3.5 away) Contact site
  • 74 views
  • 28 Jun, 2021
  • +78 other locations
Immune Modulators for Treating COVID-19

ACTIV-1 IM is a master protocol designed to evaluate multiple investigational agents for the treatment of moderately or severely ill patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The research objectives are to evaluate each agent with respect to speed of recovery, mortality, illness severity, and hospital resource …

Hospital Central FAP
 (3.8 away) Contact site
  • 0 views
  • 11 Jul, 2021
  • +84 other locations
A Study Evaluating the Efficacy and Safety of Obinutuzumab in Participants With Primary Membranous Nephropathy

This study will evaluate the efficacy, safety, pharmacodynamics, and pharmacokinetics (PK) of obinutuzumab compared with tacrolimus in participants with primary membranous nephropathy (pMN).

Clinica Internacional - Sede San Borja
 (4.7 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +77 other locations
Protecting Households On Exposure to Newly Diagnosed Index Multidrug-Resistant Tuberculosis Patients

The purpose of this study is to compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing confirmed or probable active tuberculosis (TB) during 96 weeks of follow-up among high-risk household contacts (HHCs) of adults with multidrug-resistant tuberculosis (MDR-TB) (index cases). …

hhcs
atazanavir
antibody test
hiv test
absolute neutrophil count
Barranco CRS
 (3.0 away) Contact site
  • 137 views
  • 01 Aug, 2021
  • +28 other locations
Trial to Determine the Efficacy/Safety of Plitidepsin vs Control in Patients With Moderate COVID-19 Infection

Treatment of patients hospitalised for management of moderate COVID-19 infection

Hospital Nacional Hipolito Unanue (HNHU)
 (7.7 away) Contact site
  • 0 views
  • 02 Aug, 2021
  • +76 other locations
Oral Islatravir (MK-8591) Once-Monthly as Preexposure Prophylaxis (PrEP) in Men and Transgender Women Who Have Sex With Men and Are at High Risk for HIV-1 Infection (MK-8591-024)

The main purpose of the study is to evaluate the efficacy and safety of oral Islatravir (ISL) once monthly (QM) as Preexposure Prophylaxis (PrEP) in cisgender men who have sex with men (MSM) and transgender women (TGW) who have sex with men and who are at high risk of HIV-1 …

Via Libre ( Site 0404)
 (8.2 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +16 other locations
The Efficacy and Safety of SCTA01 in Hospitalized Patients With Severe COVID-19

The study is a multicenter, adaptive, randomized, double-blinded and placebo-controlled Phase II/III trial, and will be conducted globally. The study is comprised of two parts: dose selection (Phase II) and pivotal treatment effect (Phase III).

SCT study site
 (8.8 away) Contact site
  • 0 views
  • 21 Apr, 2021
  • +6 other locations